Understanding the Role of Alpha Receptors in Pain Management

Brain Activity

α1-adrenergic alpha receptors are G-Protein Coupled Receptors that are involved in neurotransmission and regulate the sympathetic nervous system through binding and activating the neurotransmitter, norepinephrine, and the neurohormone, epinephrine. This receptor plays a key role in several neurological systems and several neurological diseases that are associated with the NE system.

In instances in which there is hypoperfusion secondary to decreased cardiac output or decreased systemic vasculature resistance, alpha-1 receptors become stimulated.

a

Like what you’re learning?  Download a brochure for our Orofacial Pain and Oral Medicine certificate or master’s degree program in partnership with the Keck School of Medicine of USC.

Alpha-1 agonists are a class of medications used in the management of many disorders, including vasodilatory shock, hypotension, hypoperfusion, septic shock, cardiopulmonary arrest, heart failure decompensation, as well as other lower acuity conditions.
The alpha-1 adrenergic receptor antagonists (also called alpha-blockers) are a family of agents that bind to and inhibit type 1 alpha-adrenergic receptors and thus inhibit smooth muscle contraction. Their major uses are for hypertension and for symptomatic benign prostatic hypertrophy.

The increase in α1 -adrenoceptor expression after nerve and tissue injury could have important clinical implications in neuropathic pain syndromes. It becomes expressed in primary afferent nociceptors (C fibers), and releases norepinephrine, changing ion channel properties.

For Pain Management, You Want an Alpha 1 Antagonist, Such as Phentolamine.

The α2-adrenoreceptors are located on both pre-and postsynaptic neurons, where they mediate an inhibitory role in the central and peripheral nervous system. Alpha 2 receptors in the brain stem and in the periphery inhibit sympathetic activity and thus lower blood pressure.

Alpha 2 is an auto-receptor with a “feedback switch”, which can control the release of NE.

Increased activity of alpha 2 receptor inhibits NE release.

For Pain Management, You Want an Alpha 1 Agonist, Such as Clonidine.

Earn an Online Postgraduate Degree in Orofacial Pain and Oral Medicine

Like what you’re learning? Consider enrolling in the Herman Ostrow School of Dentistry of USC’s online, competency-based certificate or master’s program in Orofacial Pain and Oral Medicine in partnership with the Keck School of Medicine of USC.

References

  • Taylor BN, Cassagnol M. Alpha Adrenergic Receptors. [Updated 2021 Jul 13]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539830/
  • Reid JL. Central alpha 2 receptors and the regulation of blood pressure in humans. J Cardiovasc Pharmacol. 1985;7 Suppl 8:S45-50. PMID: 2417053.

Author

  • Mariela Padilla

    Dr. Padilla obtained her DDS in 1989 at UCR, and in 1998 completed a Residency Program in Orofacial Pain at UCLA. In 2005, she obtained her Master’s Degree in Education and Curriculum Design. Dr. Padilla started her clinical practice as a general dentist in 1990, and then dedicated herself solely to Orofacial Pain and Temporomandibular Disorders. She designs programs and academic experiences for working professionals, and contributes with learning innovation and teaching development.

The information and resources contained on this website are for informational purposes only and are not intended to assess, diagnose, or treat any medical and/or mental health disease or condition. The use of this website does not imply nor establish any type of provider-client relationship. Furthermore, the information obtained from this site should not be considered a substitute for a thorough medical and/or mental health evaluation by an appropriately credentialed and licensed professional. Commercial supporters are not involved in the content development or editorial process.
Posted: May 5, 2023

Author

  • Mariela Padilla

    Dr. Padilla obtained her DDS in 1989 at UCR, and in 1998 completed a Residency Program in Orofacial Pain at UCLA. In 2005, she obtained her Master’s Degree in Education and Curriculum Design. Dr. Padilla started her clinical practice as a general dentist in 1990, and then dedicated herself solely to Orofacial Pain and Temporomandibular Disorders. She designs programs and academic experiences for working professionals, and contributes with learning innovation and teaching development.

Pin It on Pinterest

Share This